Brush Clinical Research

Brush Clinical Research is a UK-based clinical research organization (CRO) and consultancy that provides specialized support for clinical trials, with a strong focus on endocrinology and metabolic health. The company offers services in study design, regulatory strategy, and trial management, collaborating with pharmaceutical sponsors and other research organizations to execute Phase 1 and Phase 2 studies. Brush Clinical Research has been involved in the development of various hormone replacement therapies and treatments for adrenal insufficiency, including modified-release hydrocortisone and testosterone formulations. Headquartered in North Yorkshire, the firm has been an active participant in the clinical research sector since its founding in 2002. It frequently partners with larger CROs and academic institutions to facilitate complex bioavailability and bioequivalence studies.